Published in PLoS One on April 07, 2010
Dietary iron controls circadian hepatic glucose metabolism through heme synthesis. Diabetes (2014) 1.46
Common data elements for clinical research in Friedreich's ataxia. Mov Disord (2012) 1.14
Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol Aging (2013) 1.07
Understanding the genetic and molecular pathogenesis of Friedreich's ataxia through animal and cellular models. Dis Model Mech (2012) 1.04
Friedreich's ataxia: the vicious circle hypothesis revisited. BMC Med (2011) 1.00
Nitrite activates AMP kinase to stimulate mitochondrial biogenesis independent of soluble guanylate cyclase. Free Radic Biol Med (2012) 0.99
PGC-1α buffers ROS-mediated removal of mitochondria during myogenesis. Cell Death Dis (2014) 0.90
Current and emerging treatment options in the management of Friedreich ataxia. Neuropsychiatr Dis Treat (2010) 0.89
Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models. PLoS One (2014) 0.87
Nrf2 deficiency promotes apoptosis and impairs PAX7/MyoD expression in aging skeletal muscle cells. Free Radic Biol Med (2014) 0.87
An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels. J Neurol (2015) 0.84
Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia. PLoS One (2013) 0.83
Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia. Br J Pharmacol (2014) 0.83
Friedreich ataxia: new pathways. J Child Neurol (2012) 0.82
Differential expression of PGC-1α and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts. PLoS One (2011) 0.81
Oxidative stress in inherited mitochondrial diseases. Free Radic Biol Med (2015) 0.81
Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts. PLoS One (2011) 0.81
Redox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism. J Inherit Metab Dis (2015) 0.79
Cerebellar transcriptional alterations with Purkinje cell dysfunction and loss in mice lacking PGC-1α. Front Cell Neurosci (2015) 0.78
Therapies in inborn errors of oxidative metabolism. Trends Endocrinol Metab (2012) 0.78
Frataxin Deficiency Promotes Excess Microglial DNA Damage and Inflammation that Is Rescued by PJ34. PLoS One (2016) 0.76
Activation of AMPK attenuates LPS-induced acute lung injury by upregulation of PGC1α and SOD1. Exp Ther Med (2016) 0.75
Friedreich's Ataxia: A Neuronal Point of View on the Oxidative Stress Hypothesis. Antioxidants (Basel) (2014) 0.75
Disrupted mitochondrial genes and inflammation following stroke. Life Sci (2016) 0.75
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model. Ann Neurol (2017) 0.75
Time-resolved functional analysis of acute impairment of frataxin expression in an inducible cell model of Friedreich ataxia. Biol Open (2016) 0.75
Clinical monitoring in a patient with Friedreich ataxia and osteogenic sarcoma. J Child Neurol (2012) 0.75
Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells. Cerebellum (2017) 0.75
Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell (1999) 19.48
Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science (1996) 11.59
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell (2006) 10.18
Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev (2003) 9.93
Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell (2004) 8.58
Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev (2006) 6.68
Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A (2004) 6.53
PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol (2005) 5.80
The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol (2006) 5.33
Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev (1997) 4.76
Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab (2005) 4.65
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol (2006) 4.25
Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem (2003) 4.12
PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol (2009) 4.09
Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science (1997) 3.94
Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet (2001) 3.10
Retracted Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab (2008) 2.80
PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res (2005) 2.43
Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. FEBS Lett (1997) 2.24
Sticky DNA: self-association properties of long GAA.TTC repeats in R.R.Y triplex structures from Friedreich's ataxia. Mol Cell (1999) 2.21
Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat Rev Mol Cell Biol (2005) 2.17
HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS One (2008) 2.08
Oxidative stress in patients with Friedreich ataxia. Neurology (2000) 2.03
A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen. Mol Cell Biol (2000) 1.99
Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response. Aging Cell (2007) 1.87
Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia. Hum Mol Genet (2009) 1.85
Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med (2008) 1.83
Frataxin-mediated iron delivery to ferrochelatase in the final step of heme biosynthesis. J Biol Chem (2004) 1.80
Friedreich ataxia: an overview. J Med Genet (2000) 1.79
The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet (1999) 1.75
GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics (2006) 1.70
Monomeric yeast frataxin is an iron-binding protein. Biochemistry (2006) 1.67
Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet (2000) 1.66
ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl Pharmacol (2009) 1.63
A persistent RNA.DNA hybrid formed by transcription of the Friedreich ataxia triplet repeat in live bacteria, and by T7 RNAP in vitro. Nucleic Acids Res (2007) 1.63
Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics (1999) 1.53
Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2007) 1.52
Increased levels of plasma malondialdehyde in Friedreich ataxia. Neurology (2000) 1.51
Iron binding and oxidation kinetics in frataxin CyaY of Escherichia coli. J Mol Biol (2004) 1.42
Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. Hum Mol Genet (2001) 1.41
Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes. J Biol Chem (2009) 1.40
Yeast frataxin sequentially chaperones and stores iron by coupling protein assembly with iron oxidation. J Biol Chem (2003) 1.39
The role of PGC-1alpha on mitochondrial function and apoptotic susceptibility in muscle. Am J Physiol Cell Physiol (2009) 1.36
Regulation and co-ordination of nuclear gene expression during mitochondrial biogenesis. Exp Physiol (2003) 1.36
AMP-activated protein kinase-regulated activation of the PGC-1alpha promoter in skeletal muscle cells. PLoS One (2008) 1.32
The structures of frataxin oligomers reveal the mechanism for the delivery and detoxification of iron. Structure (2006) 1.31
Genetic data and natural history of Friedreich's disease: a study of 80 Italian patients. J Neurol (1990) 1.26
Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS One (2009) 1.25
Reduction in frataxin causes progressive accumulation of mitochondrial damage. Hum Mol Genet (2003) 1.24
Frataxin is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues. Hum Mol Genet (2007) 1.23
Glutathione in blood of patients with Friedreich's ataxia. Eur J Clin Invest (2001) 1.22
PPARgamma stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss. Neurochem Int (2009) 1.15
Glucose metabolism alterations in Friedreich's ataxia. Neurology (1988) 1.15
Oxidative stress and protease dysfunction in the yeast model of Friedreich ataxia. Free Radic Biol Med (2007) 1.12
Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells. Hum Mol Genet (2003) 1.09
Transcriptional activation of adipogenesis. Curr Opin Cell Biol (1999) 1.09
Friedreich ataxia. Semin Pediatr Neurol (2003) 1.06
PGC-1alpha is required for training-induced prevention of age-associated decline in mitochondrial enzymes in mouse skeletal muscle. Exp Gerontol (2010) 1.06
Transcriptional control of energy homeostasis through the PGC1 coactivators. Novartis Found Symp (2007) 1.03
The phylogenetic distribution of frataxin indicates a role in iron-sulfur cluster protein assembly. Hum Mol Genet (2001) 1.02
Accuracy of clinical diagnostic criteria for Friedreich's ataxia. Mov Disord (2000) 1.02
TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis. Biochem Biophys Res Commun (2008) 1.01
AMP-activated protein kinase control of fat metabolism in skeletal muscle. Acta Physiol (Oxf) (2009) 1.00
Rescue of the Friedreich's ataxia knockout mouse by human YAC transgenesis. Neurogenetics (2001) 1.00
Friedreich's ataxia: from disease mechanisms to therapeutic interventions. Antioxid Redox Signal (2006) 0.99
Manganese superoxide dismutase induction by iron is impaired in Friedreich ataxia cells. FEBS Lett (2001) 0.98
Structure of frataxin iron cores: an X-ray absorption spectroscopic study. Biochemistry (2003) 0.96
PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy. Cerebellum (2008) 0.95
Multicellular models of Friedreich ataxia. J Neurol (2009) 0.91
Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy. Cerebellum (2009) 0.89
Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells. Hum Mol Genet (2002) 0.87
Frataxin deficiency enhances apoptosis in cells differentiating into neuroectoderm. Hum Mol Genet (2001) 0.86
Glucose and insulin metabolism in Friedreich's ataxia. Can J Neurol Sci (1976) 0.86
Metallosensors, the ups and downs of gene regulation. Adv Microb Physiol (2008) 0.85
Secondary abnormalities of mitochondrial DNA associated with neurodegeneration. Biochem Soc Symp (1999) 0.82
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med (2011) 3.93
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol (2007) 2.88
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet (2004) 2.75
Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet (2010) 2.61
Generation of functional thyroid from embryonic stem cells. Nature (2012) 2.33
Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet (2013) 2.10
Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol (2009) 2.09
HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS One (2008) 2.08
Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain (2013) 1.95
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Ann Neurol (2006) 1.87
Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia. Hum Mol Genet (2009) 1.85
p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem (2006) 1.84
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain (2010) 1.67
Consensus paper: the cerebellum's role in movement and cognition. Cerebellum (2014) 1.67
Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model. PLoS One (2010) 1.58
Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry (2010) 1.49
Frataxin knockin mouse. FEBS Lett (2002) 1.47
Characteristics and outcomes of patients with multiple cervical artery dissection. Stroke (2013) 1.46
Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol (2007) 1.40
Science, art, and mistery in the statues and in the anatomical machines of the prince of sansevero: the masterpieces of the "Sansevero Chapel". Am J Med Genet A (2013) 1.39
Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc Natl Acad Sci U S A (2010) 1.31
Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage (2009) 1.29
The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet (2004) 1.29
Progressive GAA expansions in dorsal root ganglia of Friedreich's ataxia patients. Ann Neurol (2007) 1.29
Variant on 9p21 strongly associates with coronary heart disease, but lacks association with common stroke. Eur J Hum Genet (2009) 1.22
Common data elements for clinical research in Friedreich's ataxia. Mov Disord (2012) 1.14
Genome-wide scan for signatures of human population differentiation and their relationship with natural selection, functional pathways and diseases. PLoS One (2009) 1.14
Somatic instability of the expanded GAA triplet-repeat sequence in Friedreich ataxia progresses throughout life. Genomics (2007) 1.13
Gene expression profiling in frataxin deficient mice: microarray evidence for significant expression changes without detectable neurodegeneration. Neurobiol Dis (2006) 1.13
Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia. Dis Model Mech (2012) 1.13
Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1. Hum Mol Genet (2007) 1.12
Epigenetic therapy for Friedreich ataxia. Ann Neurol (2014) 1.11
PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation. Am J Physiol Gastrointest Liver Physiol (2007) 1.10
Replication-mediated instability of the GAA triplet repeat mutation in Friedreich ataxia. Nucleic Acids Res (2004) 1.10
Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1. J Neurosci (2011) 1.08
Mutations in TNK2 in severe autosomal recessive infantile onset epilepsy. Ann Neurol (2013) 1.07
The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease. Neurogenetics (2005) 1.06
Extra-mitochondrial localisation of frataxin and its association with IscU1 during enterocyte-like differentiation of the human colon adenocarcinoma cell line Caco-2. J Cell Sci (2005) 1.03
Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes. Ann Neurol (2012) 1.02
The neurological presentation of ceruloplasmin gene mutations. Eur Neurol (2008) 1.02
Recombinant human erythropoietin increases frataxin protein expression without increasing mRNA expression. Cerebellum (2008) 1.01
Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia. J Neurochem (2013) 1.01
Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. Epilepsia (2004) 1.01
Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease. Hum Genet (2006) 1.00
Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain (2013) 1.00
Falls in spinocerebellar ataxias: Results of the EuroSCA Fall Study. Cerebellum (2010) 0.98
Is essential tremor a Purkinjopathy? The role of the cerebellar cortex in its pathogenesis. Mov Disord (2013) 0.98
Impaired neuromuscular transmission and skeletal muscle fiber necrosis in mice lacking Na/Ca exchanger 3. J Clin Invest (2004) 0.97
Hemicerebellectomy blocks the enhancement of cortical motor output associated with repetitive somatosensory stimulation in the rat. J Physiol (2005) 0.97
Grafting neural precursor cells promotes functional recovery in an SCA1 mouse model. J Neurosci (2009) 0.95
PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy. Cerebellum (2008) 0.95
Topography of cerebellar deficits in humans. Cerebellum (2012) 0.94
A gene expression phenotype in lymphocytes from Friedreich ataxia patients. Ann Neurol (2011) 0.94
Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings. Cerebellum (2012) 0.93
Development of histone deacetylase inhibitors as therapeutics for neurological disease. Future Neurol (2009) 0.93
The cerebellum modulates rodent cortical motor output after repetitive somatosensory stimulation. Neurosurgery (2005) 0.93
Effects of trains of high-frequency stimulation of the premotor/supplementary motor area on conditioned corticomotor responses in hemicerebellectomized rats. Exp Neurol (2008) 0.93
Proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke. PLoS One (2007) 0.92
Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit. Mov Disord (2010) 0.91
Anodal transcranial direct current stimulation (tDCS) decreases the amplitudes of long-latency stretch reflexes in cerebellar ataxia. Ann Biomed Eng (2013) 0.90
Neurological tremor: sensors, signal processing and emerging applications. Sensors (Basel) (2010) 0.89
Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy. Cerebellum (2009) 0.89
A real-time PCR approach to evaluate adipogenic potential of amniotic fluid-derived human mesenchymal stem cells. Stem Cells Dev (2006) 0.89
Autosomal recessive cerebellar ataxia of adult onset due to STUB1 mutations. Neurology (2014) 0.89
Gene set enrichment analyses revealed several affected pathways in Niemann-pick disease type C fibroblasts. DNA Cell Biol (2007) 0.89
Gene set enrichment analysis reveals several globally affected pathways due to SKI-1/S1P inhibition in HepG2 cells. DNA Cell Biol (2007) 0.88
Mechanical suppression of essential tremor. Cerebellum (2007) 0.88
Trains of transcranial direct current stimulation antagonize motor cortex hypoexcitability induced by acute hemicerebellectomy. J Neurosurg (2009) 0.88
Normal left ventricular ejection fraction and mass but subclinical myocardial dysfunction in patients with Friedreich's ataxia. Eur Heart J Cardiovasc Imaging (2011) 0.87
Triplet repeat instability correlates with dinucleotide instability in primary breast cancer. Oncol Rep (2007) 0.87
Multifaceted role of galectin-3 on human glioblastoma cell motility. Biochem Biophys Res Commun (2004) 0.87
Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells. Hum Mol Genet (2002) 0.87
Blood-brain barrier promotes differentiation of human fetal neural precursor cells. Stem Cells (2009) 0.87
Beta2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus. BMC Med Genet (2006) 0.87
Suggestive evidence for a new locus for epilepsy with heterogeneous phenotypes on chromosome 17q. Epilepsy Res (2009) 0.86
Eight novel mutations in SPG4 in a large sample of patients with hereditary spastic paraplegia. Arch Neurol (2006) 0.86
Cerebellar and afferent ataxias. Continuum (Minneap Minn) (2013) 0.86
A new clinical and molecular form of Unverricht-Lundborg disease localized by homozygosity mapping. Brain (2005) 0.85
Dissecting the links between cerebellum and dystonia. Cerebellum (2014) 0.85
Depression of extra-cellular GABA and increase of NMDA-induced nitric oxide following acute intra-nuclear administration of alcohol in the cerebellar nuclei of the rat. Cerebellum (2005) 0.85
Ordered motor-unit firing behavior in acute cerebellar stroke. J Neurophysiol (2006) 0.85
Trains of epidural DC stimulation of the cerebellum tune corticomotor excitability. Neural Plast (2013) 0.85
Variants of the KCNMB3 regulatory subunit of maxi BK channels affect channel inactivation. Physiol Genomics (2003) 0.85
Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet (2004) 0.85
Shorter telomeres in patients with cerebral autosomal dominant arteriopathy and leukoencephalopathy (CADASIL). Neurogenetics (2011) 0.84
Antioxidants and other pharmacological treatments for Friedreich ataxia. Cochrane Database Syst Rev (2009) 0.84
Schizophrenia and vitamin D related genes could have been subject to latitude-driven adaptation. BMC Evol Biol (2010) 0.84
Identification of a novel transcript of X25, the human gene involved in Friedreich ataxia. Neurosci Lett (2002) 0.83
CpG islands undermethylation in human genomic regions under selective pressure. PLoS One (2011) 0.83
Cerebellar disorders--at the crossroad of molecular pathways and diagnosis. Cerebellum (2009) 0.83
Real-time PCR and linkage studies to identify carriers presenting HPRT deleted gene. Mol Med (2007) 0.83